mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.4 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |